Cart
sales@molnova.com
Collagen proline hydroxylase inhibitor-1
CAS No. 223663-32-9
Collagen proline hydroxylase inhibitor-1( —— )
Catalog No. M32853 CAS No. 223663-32-9
Collagen proline hydroxylase inhibitor-1 exhibits antifibroproliferative activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 191 | In Stock |
|
| 10MG | 259 | In Stock |
|
| 25MG | 394 | In Stock |
|
| 50MG | 520 | In Stock |
|
| 100MG | 684 | In Stock |
|
| 200MG | 905 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCollagen proline hydroxylase inhibitor-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCollagen proline hydroxylase inhibitor-1 exhibits antifibroproliferative activity.
-
DescriptionCollagen proline hydroxylase inhibitor-1 is an antifibroproliferative agents.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number223663-32-9
-
Formula Weight443.45
-
Molecular FormulaC24H21N5O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C2=C(C=3C(=CC(C(=O)N4CCN(CC5=CC=CC=C5)CC4)=CN3)C=C2)NC=C1N(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
A-18-F-NH2 |Morphine...
Neuropeptide AF (cattle), an amidated octadecapeptide, is RFamide neuropeptide. Neuropeptide AF (cattle) acts as a ligand of Mas-related gene receptor A4 (MrgprA4) (Mas-related G-protein-coupled Receptor (MRGPR)) (EC50 of ~60 nM) and MrgprC11 (EC50 of ~300 nM). Neuropeptide AF (cattle) also activate to the G protein-coupled receptors NPFF1 (Neuropeptide Y Receptor) (EC50 of ~25-325 nM) and NPFF2 (EC50 of ~1-5 nM). Neuropeptide AF (cattle) shows anti-opiate and related pain modulation effects.
-
Pencycuron
Pencycuron is a phenylurea fungicide.
-
WAY-324820-A
WAY-324820-A can be used as a QSAR model to study methionine aminopeptidase inhibitor as an anticancer agent using multiple linear regression.
